# LifeStance Health Group, Inc.: filings

LFST · Nasdaq · CIK 1845257 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lfst.md) · [Financials](/companies/lfst/financials.md) · [Filings](/companies/lfst/filings.md) · [Insiders](/companies/lfst/insiders.md)

## Reports and events: 75 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 217, 144 79, 8-K 46, 3 38, 10-Q 16, 3/A 11, SCHEDULE 13G/A 10, SC 13G/A 9, 424B7 8, CORRESP 7, UPLOAD 7, S-8 6, 10-K 5, 4/A 5, DEF 14A 5, DEFA14A 5, SC 13G 5, ARS 4, DRSLTR 3, DRS/A 2, S-1/A 2, 144/A 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, EFFECT 1, S-1 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 21:26 ET | [8-K](/filings/0001193125-26-424294.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-424294 |
| 2026-09-11 | 20:24 ET | [8-K](/filings/0001193125-26-389315.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389315 |
| 2026-08-06 | 20:21 ET | [10-Q](/filings/0001193125-26-338107.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338107 |
| 2026-08-06 | 00:21 ET | [8-K](/filings/0001193125-26-336057.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-336057 |
| 2026-07-07 | 20:27 ET | [8-K](/filings/0001193125-26-297525.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-297525 |
| 2026-06-04 | 20:46 ET | [8-K](/filings/0001193125-26-257606.md) | 5.07 Shareholder vote results | 0001193125-26-257606 |
| 2026-05-12 | 20:43 ET | [8-K](/filings/0001193125-26-219669.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-219669 |
| 2026-05-07 | 20:00 ET | [10-Q](/filings/0001193125-26-211814.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211814 |
| 2026-05-07 | 23:43 ET | [8-K](/filings/0001193125-26-209709.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-209709 |
| 2026-04-22 | 21:08 ET | [DEF 14A](/filings/0001193125-26-170798.md) | Proxy statement, period 2026-06-02 | 0001193125-26-170798 |
| 2026-03-11 | 21:16 ET | [8-K](/filings/0001193125-26-102436.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-102436 |
| 2026-03-02 | 21:30 ET | [8-K](/filings/0001193125-26-085507.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-085507 |
| 2026-02-25 | 21:00 ET | [10-K](/filings/0001193125-26-071462.md) | Annual report, period 2025-12-31 | 0001193125-26-071462 |
| 2026-02-25 | 00:18 ET | [8-K](/filings/0001193125-26-067858.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-067858 |
| 2025-11-06 | 21:29 ET | [10-Q](/filings/0001193125-25-269712.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269712 |
| 2025-11-06 | 23:41 ET | [8-K](/filings/0001193125-25-267443.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-267443 |
| 2025-08-22 | 20:39 ET | [8-K](/filings/0001193125-25-186460.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-186460 |
| 2025-08-07 | 20:29 ET | [10-Q](/filings/0000950170-25-105096.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105096 |
| 2025-08-07 | 23:03 ET | [8-K](/filings/0000950170-25-104363.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-104363 |
| 2025-06-06 | 11:30 ET | [8-K](/filings/0001193125-25-136309.md) | 5.07 Shareholder vote results | 0001193125-25-136309 |
| 2025-05-14 | 13:34 ET | [8-K](/filings/0001193125-25-119479.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-119479 |
| 2025-05-07 | 20:42 ET | [10-Q](/filings/0000950170-25-065806.md) | Quarterly report, period 2025-03-31 | 0000950170-25-065806 |
| 2025-05-07 | 22:33 ET | [8-K](/filings/0000950170-25-064745.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-064745 |
| 2025-04-23 | 20:50 ET | [DEF 14A](/filings/0000950170-25-057496.md) | Proxy statement, period 2025-06-03 | 0000950170-25-057496 |
| 2025-02-27 | 21:26 ET | [10-K](/filings/0000950170-25-029100.md) | Annual report, period 2024-12-31 | 0000950170-25-029100 |
| 2025-02-27 | 11:08 ET | [8-K](/filings/0001193125-25-037533.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-037533 |
| 2025-02-27 | 23:51 ET | [8-K](/filings/0000950170-25-028099.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-028099 |
| 2024-12-19 | 21:30 ET | [8-K](/filings/0001193125-24-282043.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0001193125-24-282043 |
| 2024-11-07 | 21:15 ET | [10-Q](/filings/0000950170-24-123376.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123376 |
| 2024-11-07 | 23:34 ET | [8-K](/filings/0000950170-24-122575.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-122575 |
| 2024-08-08 | 20:35 ET | [10-Q](/filings/0000950170-24-094105.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094105 |
| 2024-08-08 | 22:42 ET | [8-K](/filings/0000950170-24-093114.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-093114 |
| 2024-07-03 | 20:31 ET | [8-K](/filings/0001193125-24-175071.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-175071 |
| 2024-06-04 | 20:27 ET | [8-K](/filings/0001193125-24-154291.md) | 5.07 Shareholder vote results | 0001193125-24-154291 |
| 2024-05-24 | 13:16 ET | [8-K](/filings/0001193125-24-146587.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-146587 |
| 2024-05-09 | 20:15 ET | [10-Q](/filings/0000950170-24-056989.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056989 |
| 2024-05-09 | 23:26 ET | [8-K](/filings/0000950170-24-056089.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-056089 |
| 2024-04-23 | 20:25 ET | [DEF 14A](/filings/0000950170-24-046929.md) | Proxy statement, period 2024-06-03 | 0000950170-24-046929 |
| 2024-03-12 | 13:09 ET | [8-K](/filings/0000950170-24-029684.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-029684 |
| 2024-02-28 | 21:23 ET | [10-K](/filings/0000950170-24-022131.md) | Annual report, period 2023-12-31 | 0000950170-24-022131 |
| 2024-02-28 | 23:39 ET | [8-K](/filings/0000950170-24-021511.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-021511 |
| 2024-02-02 | 11:05 ET | [8-K](/filings/0001193125-24-022199.md) | 2.02 Results of operations; 8.01 Other events | 0001193125-24-022199 |
| 2023-11-08 | 21:12 ET | [10-Q](/filings/0000950170-23-061118.md) | Quarterly report, period 2023-09-30 | 0000950170-23-061118 |
| 2023-11-08 | 23:27 ET | [8-K](/filings/0000950170-23-060505.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-060505 |
| 2023-08-09 | 20:26 ET | [10-Q](/filings/0000950170-23-040649.md) | Quarterly report, period 2023-06-30 | 0000950170-23-040649 |
| 2023-08-09 | 22:40 ET | [8-K](/filings/0000950170-23-040033.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-040033 |
| 2023-06-02 | 10:07 ET | [8-K](/filings/0001193125-23-159318.md) | 5.07 Shareholder vote results | 0001193125-23-159318 |
| 2023-05-10 | 20:17 ET | [10-Q](/filings/0000950170-23-020544.md) | Quarterly report, period 2023-03-31 | 0000950170-23-020544 |
| 2023-05-10 | 22:11 ET | [8-K](/filings/0000950170-23-019901.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-019901 |
| 2023-04-21 | 20:18 ET | [DEF 14A](/filings/0000950170-23-013853.md) | Proxy statement, period 2023-06-01 | 0000950170-23-013853 |

Page 1 of 2. [Older](/companies/lfst/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.